Protagenic Therapeutics (PTIX) said Tuesday that it has struck a deal to sell about 1.95 million shares, series A warrants and series B warrants to raise about $1.275 million for working capital.
The purchase price of each share and associated warrants will be $0.64, the firm said. It expects to close the offering Nov 4, with Brookline Capital Markets, a division of Arcadia Securities, as the placement agent.
The stock was down more than 10% in recent trading.
Price: 0.57, Change: -0.07, Percent Change: -10.49
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments